6,720 Shares of Xometry, Inc. $XMTR Purchased by Park Avenue Securities LLC

Park Avenue Securities LLC acquired a new stake in shares of Xometry, Inc. (NASDAQ:XMTR) in the 3rd quarter, HoldingsChannel reports. The firm acquired 6,720 shares of the company’s stock, valued at approximately $691,000.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Abel Hall LLC increased its holdings in shares of Xometry by 5.2% in the third quarter. Abel Hall LLC now owns 2,246 shares of the company’s stock valued at $231,000 after purchasing an additional 111 shares during the period. GAMMA Investing LLC raised its stake in shares of Xometry by 36.5% during the third quarter. GAMMA Investing LLC now owns 958 shares of the company’s stock worth $99,000 after purchasing an additional 256 shares during the last quarter. Rockefeller Capital Management L.P. raised its stake in shares of Xometry by 9.7% during the fourth quarter. Rockefeller Capital Management L.P. now owns 3,270 shares of the company’s stock worth $194,000 after purchasing an additional 290 shares during the last quarter. Corient Private Wealth LP raised its stake in shares of Xometry by 1.6% during the second quarter. Corient Private Wealth LP now owns 23,196 shares of the company’s stock worth $2,239,000 after purchasing an additional 360 shares during the last quarter. Finally, Integrated Wealth Concepts LLC acquired a new stake in shares of Xometry during the second quarter worth $36,000. 97.31% of the stock is owned by institutional investors and hedge funds.

Xometry Price Performance

Shares of NASDAQ:XMTR opened at $113.52 on Thursday. Xometry, Inc. has a 52 week low of $35.86 and a 52 week high of $117.50. The company has a 50-day moving average price of $97.42 and a 200 day moving average price of $76.71. The company has a market cap of $5.88 billion, a P/E ratio of -333.87 and a beta of 1.33. The company has a quick ratio of 3.20, a current ratio of 3.21 and a debt-to-equity ratio of 0.41.

Xometry (NASDAQ:XMTR) last released its earnings results on Tuesday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.09. The company had revenue of $252.44 million for the quarter, compared to analysts’ expectations of $235.54 million. Xometry had a positive return on equity of 0.20% and a negative net margin of 1.97%. The firm’s quarterly revenue was up 39.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.11 EPS. Research analysts predict that Xometry, Inc. will post -0.01 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Randolph Altschuler sold 5,721 shares of the company’s stock in a transaction on Friday, October 2nd. The stock was sold at an average price of $103.32, for a total transaction of $591,093.72. Following the transaction, the director owned 423,029 shares of the company’s stock, valued at $43,707,356.28. This represents a 1.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Katharine Weymouth sold 5,000 shares of the stock in a transaction on Monday, August 31st. The stock was sold at an average price of $95.23, for a total value of $476,150.00. Following the completion of the transaction, the director owned 35,345 shares of the company’s stock, valued at $3,365,904.35. The trade was a 12.39% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 63,199 shares of company stock valued at $6,037,855 in the last three months. 9.10% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

XMTR has been the subject of several recent research reports. JPMorgan Chase & Co. increased their price target on Xometry from $120.00 to $140.00 and gave the stock an “overweight” rating in a report on Wednesday. Royal Bank Of Canada boosted their price objective on shares of Xometry from $100.00 to $117.00 and gave the company a “sector perform” rating in a research note on Wednesday. Wedbush boosted their price objective on shares of Xometry from $126.00 to $140.00 and gave the company an “outperform” rating in a research note on Wednesday. Cantor Fitzgerald upped their price objective on shares of Xometry from $110.00 to $114.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, UBS Group raised their target price on shares of Xometry from $95.00 to $108.00 and gave the stock a “neutral” rating in a research note on Wednesday. Eight research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $123.64.

Key Xometry News

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: Q3 results beat expectations. Revenue rose 40% year over year to a record $252 million, while marketplace revenue grew 43%. Reported EPS of $0.28 topped the $0.19 consensus. The earnings coverage also highlighted 20% growth in active buyers, to 93,812. Xometry Q3 results Q3 investor takeaways
• Positive Sentiment: Several analysts raised targets, signaling continued optimism. JPMorgan lifted its target to $140 and kept an overweight rating; Citizens JMP raised its target to $135 and maintained market outperform; Citigroup raised its target to $132 and assigned a buy rating; and Rosenblatt raised its target to $130 with a buy rating. Citigroup rating JPMorgan rating Citizens JMP rating
• Neutral Sentiment: Not all target revisions imply meaningful upside. UBS raised its target to $108 but kept a neutral rating, placing its estimate below the quoted share price. RBC’s new $117 target and Cantor Fitzgerald’s $114 target indicate comparatively modest upside. UBS target revision RBC target revision
• Negative Sentiment: Profitability remains a watchpoint. Despite the EPS beat, the supplied results show a negative net margin, leaving investors to assess whether rapid growth can translate into sustained profits.

Xometry Profile

Xometry, Inc (NASDAQ:XMTR) operates a technology-driven marketplace that connects businesses seeking custom parts with a network of manufacturing suppliers. Its platform uses automated pricing, manufacturability analysis and digital workflows to help customers source parts and manage production more efficiently.

The company supports a range of manufacturing processes, including CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other specialized production services.